Tower Research Capital LLC (Trc) Lyell Immunopharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 19,490 shares of LYEL stock, worth $13,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,490
Previous 8,257
136.04%
Holding current value
$13,643
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding LYEL
# of Institutions
108Shares Held
171MCall Options Held
7.7KPut Options Held
15.3K-
Mwg Management Ltd. Washington, DC20.2MShares$14.1 Million17.35% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$10.6 Million14.08% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$10.6 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$9.45 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$8.34 Million1.63% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $173M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...